Skip to main content
. Author manuscript; available in PMC: 2014 Jan 7.
Published in final edited form as: Gynecol Oncol. 2012 Apr 6;126(1):10.1016/j.ygyno.2012.03.049. doi: 10.1016/j.ygyno.2012.03.049

Figure 1.

Figure 1

Structures of Taxol-transporter conjugates and their half-lives under assay or reducing conditions: (A) Prodrug half-life under assay conditions (HBS, pH=7.4, 37°C). (B) Prodrug half-life under reducing conditions (10mM DTT, HBS, pH=7.4, 37°C).